RT Journal Article
SR Electronic
T1 A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.28.21259290
DO 10.1101/2021.06.28.21259290
A1 Sally Mortlock
A1 Rosario I. Corona
A1 Pik Fang Kho
A1 Paul Pharoah
A1 Ji-Heui Seo
A1 Matthew L. Freedman
A1 Simon A. Gayther
A1 Matthew T. Siedhoff
A1 Peter A.W. Rogers
A1 Ronald Leuchter
A1 Christine S. Walsh
A1 Ilana Cass
A1 Beth Y. Karlan
A1 B.J. Rimel
A1 Ovarian Cancer Association Consortium
A1 International Endometriosis Genetics Consortium
A1 Grant W. Montgomery
A1 Kate Lawrenson
A1 Siddhartha P. Kar
YR 2021
UL http://medrxiv.org/content/early/2021/07/02/2021.06.28.21259290.abstract
AB Endometriosis is associated with increased risk of epithelial ovarian cancers (EOCs). Data from large endometriosis and EOC genome-wide association meta-analyses were used to estimate the genetic correlation and evaluate the causal relationship between genetic liability to endometriosis and major EOC histotypes, and to identify shared susceptibility loci. We estimated a significant genetic correlation (rg) between endometriosis and clear cell (rg=0.71), endometrioid (rg=0.48) and high-grade serous (rg=0.19) ovarian cancer, all supported by Mendelian randomization analyses. A bivariate meta-analysis identified 28 loci associated with endometriosis and EOC, including two novel risk loci, and 19 with evidence for a single underlying causal variant. Differences in the shared risk suggest different underlying pathways may contribute to the relationship between endometriosis and the different histotypes. Functional annotation using transcriptomic and epigenomic profiles of relevant tissues/cells highlighted several target genes. This comprehensive analysis reveals profound genetic overlap between endometriosis and EOC histotypes with valuable genomic targets for understanding the biological mechanisms linking the diseases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Health and Medical Research Council of Australia (GNT1026033, GNT1105321, GNT1147846, Investigator Grant 1177194 to G.W.M and Medical Research Future Fund Research Grant MRF1199785 to S.M) and National Institutes of Health (R01CA193910, R01CA204954, R01CA211707, R01CA251555). S.P.K is supported by a United Kingdom Research and Innovation Future Leaders Fellowship (MR/T043202/1). K.L. is supported by a Liz Tilberis Early Career Award (599175) and a Program Project Development (373356) from the Ovarian Cancer Research Alliance, plus a Research Scholars Grant from the American Society (134005). For funding details of the endometriosis meta-analysis please see Sapkota et al. (2017). For funding details of the ovarian cancer meta-analysis please see Phelan et al. (2017).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study includes no data deposited in external repositories.